Get startedLog in
    Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logo

    RICHTER — Richter Gedeon Vegyeszeti Gyar Nyrt News Story

    0.000.00%
    hu flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    All News

    Brief: Hungary's Richter announces acquisition of stake in U.S.-based Granata Bio

    Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logoRichter Gedeon Vegyeszeti Gyar Nyrt
    13/05/2025 07:05
    May 13 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says:

ANNOUNCES ACQUISITION OF A SIGNIFICANT STAKE IN U.S.-BASED GRANATA BIO -STATEMENT

IT WILL BECOME A MAJOR INVESTOR IN GRANATA BIO AND GAIN A SEAT ON GRANATA BIO'S BOARD OF DIRECTORS -STATEMENT

COMPANIES SIGNED A BINDING TERM SHEET FOR THE CO-DEVELOPMENT OF BEMFOLA FOR THE U.S. MARKET

BEMFOLA IS RICHTER'S RECOMBINANT FOLLICLE STIMULATING HORMONE PRODUCT

COMPANIES SIGNED A ROYALTY PURCHASE AGREEMENT FOR GRANATA BIO'S HUMAN MENOPAUSAL GONADOTROPIN IN THE US, SECURING FUTURE ROYALTY INCOME FOR RICHTER

Source text: [https://bet.hu/newkibdata/129255522/GranataBio_May2025_EN.pdf]

Further company coverage: GDRB.BU

 (Reporting by Anita Komuves)

 ((KOMUVES.Anita@thomsonreuters.com;))

    Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt

    See all news